HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Albitar Selected Research

Multiple Myeloma

4/2012Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Albitar Research Topics

Disease

13Neoplasms (Cancer)
03/2007 - 01/2000
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2007 - 01/2000
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2009 - 03/2000
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2012 - 01/2001
7Leukemia
04/2004 - 06/2000
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2007 - 01/2000
5Hematologic Neoplasms (Hematological Malignancy)
03/2007 - 01/2001
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2011 - 02/2000
2Disease Progression
06/2001 - 02/2000
2Myeloid Leukemia (Leukemia, Myelocytic)
03/2001 - 11/2000
2Lymphoma (Lymphomas)
06/2000 - 03/2000
1Aplastic Anemia (Anemia, Hypoplastic)
01/2018
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2016
1Paraproteinemias (Monoclonal Gammopathy)
04/2016
1Multiple Myeloma
04/2012
1Hairy Cell Leukemia
11/2004
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2004
1Carcinogenesis
08/2003
1Myeloid Sarcoma (Chloroma)
06/2003
1Refractory Anemia with Excess of Blasts (RAEM)
11/2002
1Agranulocytosis (Granulocytopenia)
07/2001
1Splenomegaly
07/2001
1Prolymphocytic Leukemia
07/2001
1Hemorrhage
07/2001
1Pneumonia (Pneumonitis)
07/2001
1Hepatomegaly
07/2001
1Anemia
04/2001
1Neoplasm Metastasis (Metastasis)
04/2001
1Autosomal Recessive 3 Severe Congenital Neutropenia
11/2000
1Retinoblastoma (Glioblastoma, Retinal)
11/2000
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2000
1Necrosis
09/2000
1Chromosome Aberrations (Chromosome Abnormalities)
04/2000
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
06/2007 - 03/2000
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2001 - 07/2000
3Phosphotransferases (Kinase)IBA
06/2011 - 03/2001
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2001 - 09/2000
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2001 - 09/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2004 - 07/2001
2DNA (Deoxyribonucleic Acid)IBA
08/2003 - 01/2003
2angiogeninIBA
08/2001 - 01/2001
2Vincristine (Oncovin)FDA LinkGeneric
07/2001 - 01/2000
2Dexamethasone (Maxidex)FDA LinkGeneric
07/2001 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2001 - 09/2000
2Transforming Growth Factor alpha (TGF-alpha)IBA
01/2001 - 09/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2001 - 09/2000
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
04/2000 - 01/2000
1Cell-Free Nucleic AcidsIBA
01/2018
1Immunoglobulin M (IgM)IBA
04/2016
1ErythropoietinFDA Link
04/2012
1Syndecan-1 (Syndecan 1)IBA
02/2009
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2007
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2007
1Alemtuzumab (Campath)FDA Link
04/2004
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2003
1Mitochondrial DNA (mtDNA)IBA
08/2003
1Annexin A5IBA
11/2002
1Histidine (L-Histidine)FDA Link
10/2001
1AntibodiesIBA
09/2001
1Surface Antigens (Surface Antigen)IBA
09/2001
1EnzymesIBA
08/2001
1Glycoproteins (Glycoprotein)IBA
07/2001
1Hemoglobins (Hemoglobin)IBA
07/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2001
1InterferonsIBA
06/2001
1Caspase 3 (Caspase-3)IBA
06/2001
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2001
1Protein Kinase InhibitorsIBA
03/2001
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
03/2001
1Stem Cell FactorIBA
03/2001
1orantinib (SU6668)IBA
03/2001
1Semaxinib (SU5416)IBA
03/2001
1Epidermal Growth Factor (EGF)IBA
01/2001
1Angiogenesis InhibitorsIBA
01/2001
1Angiopoietin-1IBA
01/2001
1Platelet-Derived Growth FactorIBA
01/2001
1CytokinesIBA
01/2001
1Transforming Growth Factor beta (TGF-beta)IBA
01/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2000
1Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA
11/2000
1Retinoblastoma ProteinIBA
11/2000
1Oncogene Proteins (Oncogene Protein)IBA
11/2000
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2000
1Cyclin-Dependent Kinase Inhibitor p16IBA
11/2000
1Proto-Oncogene Proteins c-mdm2IBA
11/2000
1Cyclin D1IBA
06/2000
1Immunoglobulins (Immunoglobulin)IBA
04/2000
1Messenger RNA (mRNA)IBA
03/2000
1Ataxia Telangiectasia Mutated ProteinsIBA
03/2000
1Retinoic Acid Receptor alphaIBA
03/2000
1Thrombopoietin (c-mpl Ligand)IBA
02/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2000

Therapy/Procedure

8Therapeutics
04/2016 - 02/2000
2Drug Therapy (Chemotherapy)
08/2003 - 06/2003
1Stem Cell Transplantation
04/2004
1Radiotherapy
06/2003